Table 4. Correlation of Day 30 and Day 45 ddCD3 Derivative Values and Clinical Outcome on Patients in whom Data was Available to Allow Plotting of the Polynomial Curve.
| Yes | No | P | |||||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| n | Median | IQR | n | Median | IQR | ||
| dx/dy(30) | |||||||
| GVHD | 16 | 14.5 | 4.4, 16.5 | 17 | .9 | .1, 5.5 | .0026 |
| Relapse | 14 | 2.3 | −.1, 10.9 | 19 | 4.7 | 2.1, 16.0 | .0869 |
| Survival | 22 | 4.5 | .9, 15.6 | 11 | 3.7 | .3, 15.5 | .8635 |
| DLI use | 9 | .9 | .1, 5.2 | 24 | 7.1 | 1.4, 16.5 | .0476 |
| dx/dy(45) | |||||||
| GVHD | 16 | 3.4 | 1.2, 13.5 | 17 | .7 | .3, 2.3 | .0562 |
| Relapse | 14 | 1.6 | .4, 6.9 | 19 | 1.8 | .9, 10.9 | .4888 |
| Survival | 22 | 1.6 | .8, 6.5 | 11 | 1.9 | .1, 15.6 | .9848 |
| DLI use | 9 | .5 | .3, 2.0 | 24 | 2.1 | .9, 13.2 | .1149 |